Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alain Cantagrel

Showing results (1-10 of 129) with videos related to

Pageof 13
Sort By:
Joint Bone Spine|December 8, 2015
New autoantibodies associated with rheumatoid arthritis recognize posttranslationally modified self-proteinsAlain Cantagrel, Yannick Degboé
La Revue Du Praticien|December 12, 2012
[Treatment of active rheumatoid arthritis]Alain Cantagrel, Arnaud Constantin
Arthritis Research & Therapy|January 8, 2021
Cytomegalovirus infection: friend or foe in rheumatoid arthritis?Jean-Luc Davignon, Bernard Combe, Alain Cantagrel
Current Vascular Pharmacology|August 5, 2008
Impact of traditional therapies and biologics on cardiovascular diseases in rheumatoid arthritisJean-Frédéric Boyer, Alain Cantagrel, Arnaud Constantin
Joint Bone Spine|December 27, 2005
Bone and joint disease associated with primary immune deficienciesChristelle Sordet, Alain Cantagrel, Thierry Schaeverbeke, et al.
The American Journal of Medicine|July 27, 2011
Interferon alpha and pamidronate in osteoporosis with fracture secondary to mastocytosisMichel Laroche, Christina Livideanu, Carle Paul, et al.
Therapie|December 20, 2003
[Retrospective analysis of adverse effects of infliximab in a hospital rheumatology service]Cendrine Cabou, Haleh Bagheri, Alain Cantagrel, et al.
RMD Open|March 9, 2017
No impact of concomitant methotrexate use on serious adverse event and serious infection risk in patients with rheumatoid arthritis treated with bDMARDs: a systematic literature review and meta-analysisClaire Baradat, Yannick Degboé, Arnaud Constantin, et al.
Rheumatology (Oxford, England)|November 19, 2003
The 5-yr HAQ-disability is related to the first year's changes in the narrowing, rather than erosion score in patients with recent-onset rheumatoid arthritisJean Francis Maillefert, Bernard Combe, Philippe Goupille, et al.
The Journal of Biological Chemistry|March 28, 2002
Reactive oxygen species differentially affect T cell receptor-signaling pathwaysSaso Cemerski, Alain Cantagrel, Joost P M Van Meerwijk, et al.
Pageof 13

Showing results (1-10 of 129) with videos related to

Sort By:
Pageof 13
Joint Bone Spine|December 8, 2015
New autoantibodies associated with rheumatoid arthritis recognize posttranslationally modified self-proteinsAlain Cantagrel, Yannick Degboé
La Revue Du Praticien|December 12, 2012
[Treatment of active rheumatoid arthritis]Alain Cantagrel, Arnaud Constantin
Arthritis Research & Therapy|January 8, 2021
Cytomegalovirus infection: friend or foe in rheumatoid arthritis?Jean-Luc Davignon, Bernard Combe, Alain Cantagrel
Current Vascular Pharmacology|August 5, 2008
Impact of traditional therapies and biologics on cardiovascular diseases in rheumatoid arthritisJean-Frédéric Boyer, Alain Cantagrel, Arnaud Constantin
Joint Bone Spine|December 27, 2005
Bone and joint disease associated with primary immune deficienciesChristelle Sordet, Alain Cantagrel, Thierry Schaeverbeke, et al.
The American Journal of Medicine|July 27, 2011
Interferon alpha and pamidronate in osteoporosis with fracture secondary to mastocytosisMichel Laroche, Christina Livideanu, Carle Paul, et al.
Therapie|December 20, 2003
[Retrospective analysis of adverse effects of infliximab in a hospital rheumatology service]Cendrine Cabou, Haleh Bagheri, Alain Cantagrel, et al.
RMD Open|March 9, 2017
No impact of concomitant methotrexate use on serious adverse event and serious infection risk in patients with rheumatoid arthritis treated with bDMARDs: a systematic literature review and meta-analysisClaire Baradat, Yannick Degboé, Arnaud Constantin, et al.
Rheumatology (Oxford, England)|November 19, 2003
The 5-yr HAQ-disability is related to the first year's changes in the narrowing, rather than erosion score in patients with recent-onset rheumatoid arthritisJean Francis Maillefert, Bernard Combe, Philippe Goupille, et al.
The Journal of Biological Chemistry|March 28, 2002
Reactive oxygen species differentially affect T cell receptor-signaling pathwaysSaso Cemerski, Alain Cantagrel, Joost P M Van Meerwijk, et al.
Pageof 13